Immunovant (IMVT) Shares Outstanding (Diluted) (2020 - 2026)

Immunovant (IMVT) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 255.20 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 106.00 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 64.41 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 210.89 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.51 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.05 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 556.90 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 138.28 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 217.35 Mn
10 Immunovant 8.63 Bn 7.83 Bn - 205.55 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 205.55 Mn
Mar 31, 2026 182.42 Mn
Dec 31, 2025 181.51 Mn
Sep 30, 2025 173.64 Mn
Jun 30, 2025 170.87 Mn
Mar 31, 2025 151.57 Mn
Dec 31, 2024 146.92 Mn
Sep 30, 2024 146.47 Mn
Jun 30, 2024 146.09 Mn
Mar 31, 2024 138.10 Mn
Dec 31, 2023 144.52 Mn
Sep 30, 2023 131.16 Mn
Jun 30, 2023 130.50 Mn
Mar 31, 2023 123.08 Mn
Dec 31, 2022 128.57 Mn
Sep 30, 2022 116.57 Mn
Jun 30, 2022 116.56 Mn
Mar 31, 2022 109.68 Mn
Dec 31, 2021 115.03 Mn
Sep 30, 2021 109.08 Mn